Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Heath Badger"'
Autor:
Wei Tan, Alastair Thompson, Alan Montgomery, Sarah Craig, Laura Ternent, Eleanor Mitchell, Lelia Duley, Ian Ellis, Alistair Ring, Nicole Francis, Hannah Price, David Dodwell, Elizabeth Miles, Rebecca Haydock, Margaret Childs, Mara Ozolins, Diane Whitham, Apostolos Fakis, David Whynes, Patricia Fairbrother, Robert Newcombe, Malcolm Reed, Daniel Davis, Tara Homer, Kathryn Monson, Ramsey Cutress, Valerie Jenkins, Lesley Fallowfield, Clare Brittain, Daniel Rea, Judith Bliss, Amit Goyal, G Bruce Mann, Robert E Coleman, Shabina Sadiq, Heath Badger, Rachel Helen Haines, Mickey Lewis, Daniel Megias, Zohal Nabi, Preetinder Singh, Andrei Caraman, Romaana Mir, Teresa Grieve, Clare Upton, Aisha Shafayat, Charlotte Gidman, Flonda Probert, Lisa Paksec, Rose Lucas, Annette Dempsey, Rochelle Thornton, Roeum Butt, Peter Barrett Lee, Julie Wolfarth, Peter Dubsky
Publikováno v:
BMJ Open, Vol 11, Iss 12 (2021)
Externí odkaz:
https://doaj.org/article/12460454e606498ebdb4b066396a1d8f
Autor:
Amit Goyal, Cydney Bruce, Shabina Sadiq, Mickey Lewis, Alan Montgomery, G Bruce Mann, Heath Badger, Kathryn Monson, Valerie Jenkins, Lesley Fallowfield, Malcolm Reed, David Dodwell, Patricia Fairbrother, Tara Homer, Luke Vale, Roeum Butt, Elizabeth Miles, Shelley Dowey, Lucy Matthews, Hugh Jarrett, Juliet Jackson, Arfan Ali
Publikováno v:
Cancer Research. 83:P5-01
Background: POSNOC is a UK-ANZ multicentre, non-inferiority, randomised trial comparing systemic therapy alone with systemic therapy plus Axillary Treatment (Axillary radiotherapy or ALND) for women with ≤2 macrometastases at SNB. The primary outco
Autor:
Frances M. Boyle, Robin John Paterson, Prudence A. Francis, Lauren Macnab, Anne Hamilton, Rebecca Asher, Edmond M. Kwan, Emma Gibbs, Chee Khoon Lee, Geoffrey J. Lindeman, Michael Friedlander, Elizabeth Lieschke, Heath Badger, Clare L. Scott
Publikováno v:
British Journal of Cancer
Background We conducted a Phase 1 study to evaluate safety and activity of olaparib tablets and oral cyclophosphamide. Methods Patients had metastatic breast cancer (BC) or recurrent high-grade serous ovarian cancer (HGSOC), performance status 0–2,
Autor:
S Jafari, S Corachan, Kathryn P. Gray, Sherene Loi, Boon Chua, M Krishnasamy, Meredith M. Regan, J-L Martinez, Heath Badger, Andrew J. Spillane, Nicholas Zdenkowski, C Mavin, John F. Forbes, A Fong, B Mann, A Arahmani, PA Francis, N Wilcken, A Martin
Publikováno v:
Cancer Research. 79:OT2-04
Background Radiation therapy (RT) after breast conserving surgery (BCS) is the current standard of care for patients with early stage breast cancer. However, individual absolute recurrence risks and hence benefits of RT vary substantially. A study sh
Autor:
Gregory Bruce Mann, Allison Rose, Anita R. Skandarajah, Rebecca Asher, Andrew J. Spillane, Nicholas Zdenkowski, Helen Braggett, Janemary Hughes, Heath Badger, Boon Chua, John P. Collins, Arlene Mou
Publikováno v:
Cancer Research. 80:PD9-01
Background and Aim The role of staging breast magnetic resonance imaging (MRI) of apparently localised breast cancer is controversial. Some recommend MRI in selected ‘high risk’ situations, while others suggest it has little or no role. Few studi
Autor:
Jacquie Chirgwin, Frances M. Boyle, Dianne F Lindsay, Andrew Simpson, George Kannourakis, Eugene Leong, Val Gebski, John F. Forbes, James M. Bull, Anne-Sophie Veillard, E Abdi, Nicole McCarthy, Nicholas Wilcken, Linda Reaby, Diana Zannino, Heath Badger, Nicholas Zdenkowski, Prudence A. Francis
Publikováno v:
The Breast. 23:142-151
Background Neoadjuvant chemotherapy has a sound rationale for use in women with large operable breast cancer, and achievement of pathological complete response (pCR) is prognostic. Epirubicin and cyclophosphamide followed by docetaxel is a standard c
Autor:
N Wilcken, Nicole McCarthy, Val Gebski, George Kannourakis, John F. Forbes, D. F. Lindsay, A Simpson, Frances M. Boyle, E Leong, Heath Badger, J Bull
Publikováno v:
Cancer Research. 71:P3-14
Background Neoadjuvant chemotherapy may provide an early indication of treatment effect and pathologic complete response (pCR) rate is a surrogate measure of disease-free and overall survival. Anthracyclines remain an important component of chemother
Autor:
Frances M. Boyle, Clare L. Scott, Michael Friedlander, Lauren Macnab, Emma Gibbs, Chee Khoon Lee, Geoffrey J. Lindeman, Edmond M. Kwan, Heath Badger, Robin John Paterson
Publikováno v:
Journal of Clinical Oncology. 35:1104-1104
1104 Background: Poly (ADP-ribose) polymerase (PARP) inhibitors can potentiate chemotherapy induced DNA damage, through synthetic lethality, leading to increased tumor death. We hypothesized that O+C would increase antitumor activity of O through inc
Autor:
Frances M. Boyle, Heath Badger, Stephen B. Fox, Prudence A. Francis, Val Gebski, L. Murphy, Robert L. Sutherland, Belinda E Kiely, D. F. Lindsay, John F. Forbes, Kelly-Anne Phillips
Publikováno v:
Web of Science
TPS1136 Background: Targeted therapies are needed for triple negative breast cancer (BC). ERβ is expressed in at least 20% of triple negative BCs. ERβ binds estrogen and tamoxifen with a similar affinity to ERα. ERβ has 5 isoforms but only ERβ1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62e56dd367863c2ae46cb76ec7189eac
https://publons.com/wos-op/publon/19762771/
https://publons.com/wos-op/publon/19762771/